The groundbreaking approach of tirzepatide peptide represents a major advance in the care of type 2 diabetes. Different to existing drugs, tirzepatide affects two pathways – GLP-1 and the GIP hormone – leading to https://tirzepatidepeptide768164.blog-ezine.com/42606463/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment